Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection

Clinical trial NCT06849544 · COMPLETED

Trial details

NCT number: NCT06849544
Sponsor: Clinton Bahler
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Surgery Prostate Cancer Metastatic Disease

Start date: 2025-04-02
Primary completion: 2026-06-15
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.